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Abstract:           
Background: Biofilm formation by pathogens is of great clinical importance as it mediates persistence and 
resistance to antibiotics, hence posing difficulty in treatment and management of diseases. The aim of this study 
was to evaluate the biofilm forming potential of Staphylococcus aureus isolated from urine samples of females with 
urinary tract infection and to detect the presence of clumping factor (clfA) and intracellular adhesion (icaA) 
encoding genes.                                                           
Methodology: A total of 50 S. aureus were obtained from urine samples of women in five hospitals in Lagos State, 
Nigeria. Isolates were confirmed by standard biochemical and novobiocin susceptibility tests. The isolates were 
screened for biofilm formation using three methods; Congo-red agar (CRA), tube, and tissue culture plate (TCP) 
methods. Detection of clfA and icaA genes was done by PCR.         
Results: The Congo red agar method showed that 39 (78%) of the isolates were biofilm producers while 11 (22%) 
were non-biofilm producers. However, the tube method indicated that 12 (24%) were strong biofilm producers, 26 
(52%) were moderate biofilm producers, and 12 (24%) were non-biofilm producers. The standard TCP assay 
showed that strong biofilm producers (OD > 0.240) were 13 (26%), moderate biofilm producers were 22 (44%), 
and weak or non-biofilm producers (OD < 0.120) were 15 (30%). The tube method showed a good correlation 
with the TCP method for strong biofilm production. Ten (20%) isolates possessed clfA gene and 31 (62%) 
possessed icaA gene.                           
Conclusion: The ability of S. aureus to form biofilm is a key risk factor that can increase morbidity and mortality 
from infections they cause. Hence, rapid and sensitive phenotypic methods can be used in screening for biofilm 
formation thereby providing data that can guide therapy and control of the pathogen 
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Contexte: La formation de biofilm par des agents pathogènes est d'une grande importance clinique car elle 
intervient dans la persistance et la résistance aux antibiotiques, ce qui pose des difficultés dans le traitement et la 
gestion des maladies. Le but de cette étude était d'évaluer le potentiel de formation de biofilm de Staphylococcus 
aureus isolé à partir d'échantillons d'urine de femmes atteintes d'une infection des voies urinaires et de détecter la 
présence de gènes codant pour le facteur d'agglutination (clfA) et l'adhésion intracellulaire (icaA).                   
Méthodologie: Un total de 50 S. aureus a été obtenu à partir d'échantillons d'urine de femmes dans cinq hôpitaux 
de l'État de Lagos, au Nigéria. Les isolats ont été confirmés par des tests standard de sensibilité biochimique et à la 
novobiocine. Les isolats ont été criblés pour la formation de biofilm en utilisant trois méthodes; Méthodes de gélose 
au rouge Congo (CRA), de tubes et de plaques de culture tissulaire (TCP). La détection des gènes clfA et icaA a été 
réalisée par PCR.                            
Résultats: La méthode de l'agar rouge du Congo a montré que 39 (78%) des isolats étaient des producteurs de 
biofilm tandis que 11 (22%) n'étaient pas des producteurs de biofilm. Cependant, la méthode du tube a indiqué que 
12 (24%) étaient de puissants producteurs de biofilm, 26 (52%) étaient des producteurs de biofilm modérés et 12 
(24%) n'étaient pas des producteurs de biofilm. Le test TCP standard a montré que les producteurs de biofilm forts 
(DO > 0,240) étaient 13 (26%), les producteurs de biofilm modérés étaient de 22 (44%) et les producteurs de 
biofilm faibles ou non (DO < 0,120) étaient de 15 (30%). La méthode du tube a montré une bonne corrélation avec 
la méthode TCP pour une forte production de biofilm. Dix (20%) isolats possédaient le gène clfA et 31 (62%) 
possédaient le gène icaA.                             
Conclusion: La capacité de S. aureus à former un biofilm est un facteur de risque clé qui peut augmenter la 
morbidité et la mortalité dues aux infections qu'elles provoquent. Par conséquent, des méthodes phénotypiques 
rapides et sensibles peuvent être utilisées dans le dépistage de la formation de biofilm, fournissant ainsi des 
données qui peuvent guider la thérapie et le contrôle du pathogène. 
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Introduction: proteins have been involved in the biofilm 
formation process in staphylococci including 
biofilm-associated protein; surface protein G, 
fibronectin-binding proteins and staphylococcal 
protein A (5). Biofilm formation by S. aureus 
can lead to delay in re-epithelialization of 
infected tissues, ultimately increasing healing 
time. S. aureus biofilms have been associated 
with chronic wounds such as diabetic foot 
ulcer, pressure sores and venous ulcers 
(6). Detachment of matured biofilm of S. 
aureus is a prerequisite for the dissemination 
of wound infection (7).    
 In Nigeria, there is paucity of data on 
studies that characterize biofilm formation in 
pathogens of clinical origin. Hence this study is 
aimed at characterizing biofilm formation in 
clinical S. aureus isolates.  
 Biofilms are communities of bacteria 
embedded in a self-produced extracellular 
matrix made of exopolysaccharides (EPSs) 
containing proteins and some macromolecules 
such as DNA. They can form on both biotic and 
abiotic surfaces (1). Studies have shown using 
scanning electron microscopy (SEM) and other 
molecular techniques that human tissues and 
medical implants are colonized by biofilms. 
Biofilm protects the microorganism from host 
defences and impedes delivery of antibiotics 
thereby resulting in the persistence of 
infections (2,3).   
 Staphylococcus aureus is an opportu- 
nistic pathogen implicated in skin and soft 
tissue infections. It exists in the nasopharynx, 
skin, eye, intestine and urogenital tract as 
normal flora. However, it can breach the skin 
barriers through the wound or surgical incision 
and cause infection. Furthermore, it has the 
ability to adhere to and form a biofilm on 
tissues or medical indwelling devices (4). S. 
aureus initially adheres to a solid substrate, 
after which cell–cell adhesion occurs; and the 
bacteria then multiply to form a multilayered 
biofilm encased in EPS.   
 Biofilm formation involves the produc- 
tion of polysaccharide intercellular adhesin, 
which depends on the expression of the inter- 
cellular adhesion molecule operon (icaADBC) 
which encodes three membrane proteins 
(IcaA, IcaD, and IcaC) and one extracellular 
protein (IcaB). In addition, several surface 
Materials and method: 
Study setting and subjects   
 The subjects were non-pregnant 
women presenting with urinary tract infection 
in five public hospitals; Lagos University 
Teaching hospital, General Hospital Marina, 
General Hospital Gbagada, General Hospital 
Shomolu, and General Hospital Orile-Agege in 
Lagos State, Nigeria. Samples were collected 
between February 2015 and April 2017.  
Ethical approval    
 Ethical approval for this study was 
obtained from the Human Research and Ethical 
Committee (HREC) of the Lagos University 
Teaching Hospital with code number ADM/ 




DCST/HREC/879 and Health Research Ethics 
Committee of the Gbagada General Hospital 
with code number GBGH/705/100 
done in triplicate and incubated at 37˚C for 24 
to 48 hours. Culture plates that displayed black 
colonies with a dry crystalline consistency were 
noted as positive for biofilm formation while 
plates that had pink colonies with occasional 
darkening at the center were considered as 
weak or non-biofilm formers.  
Bacterial isolates    
 One millilitre of the urine sample was 
inoculated into 9mL of brain heart infusion 
broth (Oxoid, Basingstoke, UK) and incubated 
for 24 hours at 37oC. A loopful of broth culture 
was then streaked onto mannitol salt agar 
(Oxoid, Basingstoke, UK) and incubated for 24 
hours at 37oC. Yellow colonies were picked and 
sub-cultured on nutrient agar to obtain pure 
colonies. Standard biochemical tests and 
novobiocin susceptibility test to phenotypically 
confirm S. aureus were carried out according to 
Cheesbrough (8), with S. aureus ATCC 29213 
as quality control strain. 
Tissue Culture Plate (TCP) method   
 Staphylococcus aureus isolates were 
inoculated into brain heart infusion broth 
(Oxoid, Basingstoke, UK) supplemented with 
2% sucrose and incubated for 18 hours at 
37˚C. A dilution of 1in 100 with fresh medium 
was done and 200µL was dispensed into 
individual wells of sterile 96 well tissue culture 
plates. Positive control S. aureus ATCC 29213 
strain was included in separate wells, while 
negative control was sterile broth medium. The 
tissue culture plates were incubated for 18 
hours at 37˚C, after which the content of each 
well was gently removed by tapping the plates. 
The wells were washed four times with 200µL 
of phosphate buffer saline (pH 7.2) to remove 
free-floating bacteria. Biofilm formed by adhe- 
rent organisms in plate were fixed with 2% 
sodium acetate and stained with 0.1% crystal 
violet. Excess stain was washed off gently with 
deionized water and dye incorporated by the 
adherent cells was solubilized by adding 200µL 
of 33% glacial acetic acid (Merck, Darmstadt, 
Germany).     
 The optical density (OD) of each well 
was determined with an Emax® Plus Microplate 
Reader (Molecular Devices San Jose, CA) at 
wave length 570nm. The experiment was 
performed in triplicate and repeated three 
times. Absorbance was calculated by sub- 
tracting the OD570 of control from that of the 
test assays OD570 with mean value determined 
for each isolate. Data obtained were used to 
classify OD570 values < 0.120 as non-biofilm 
producers, OD570 values between 0.120-0.240 
as moderate biofilm producers, and OD570 
values > 0.240 as strong biofilm producers. 
Biofilm formation assay    
 Biofilm formation assays were per- 
formed according to Mathur et al., (9) and 
Cavant et al., (10) with slight modifications. All 
50 S. aureus isolates were tested by three 
invitro screening procedures for their ability to 
form biofilm  
Tube method      
 Staphylococcus aureus isolates were 
inoculated into brain heart infusion broth 
(Oxoid, Basingstoke, UK) and incubated for 24 
hours at 37˚C. Thereafter, spent broth were 
decanted and tubes were washed with phos- 
phate buffered saline (pH 7.3) and allowed to 
air dry, and then stained with 0.1% crystal 
violet solution. Excess stain was discarded and 
tubes were washed three times with sterile 
distilled water and dried. A positive result was 
indicated by the presence of visible film lining 
the wall and bottom of the tube. The absence 
of a film or presence of only a stained ring at 
the liquid air interface was considered as a 
negative result. Biofilm forming potential were 
categorized base on the intensity of film as 
strong (+++), moderate (++), weak (+) (9). 
S. aureus ATCC 29213 was used as positive 
control 
Molecular detection of icaA and clfA genes 
 DNA extraction was done using the 
method of Suvajdžić et al., (11). PCR was 
performed by targeting specific primers listed 
in Table 1. A 20µL PCR reaction containing 4µl 
(5x) FIREPol master mix [7.5mM MgCl2, 1Mm
Congo-Red Agar (CRA) method    
 Suspension of S. aureus isolates were 
inoculated onto brain heart infusion agar 
(Oxoid, Basingstoke, UK) supplemented with 
5% sucrose and 0.8 g/L Congo red. This was 
  
Table 1: List of primers targeted to detect icaA and clfA genes 
 
















dNTPs, 0.4M Tris-HCl, 0.1M (NH4)2SO4, 0.1% 
Tween-20, FIREPol DNA Polymerase) (Solis 
BioDyne, Estonia)], 0.6µL forward primer, 
0.6µL reverse primer, 4µL DNA template and 
10.8µL nuclease free water, was carried out in 
a Master cycler (Eppendorf AG, Hamburg, 
Germany). Amplification conditions consist of 
initial DNA denaturation at 95°C for 5min, 
followed by 35 cycles of denaturation at 95°C 
for 30s, annealing at 45°C for clfA and 54°C for 
IcaA for 30s and extension at 72°C for 2min, 
followed by a final extension at 72°C for 
10min. Amplification products were analysed 
by electrophoresis at 100V for 60min in 2% 
agarose gel stained with ethidium bromide and 
visualized under ultraviolet trans-illuminator 
(Cleaver Scientific Ltd). A 100bp DNA ladder 
(Solis BioDyne, Estonia) was used as a 
molecular weight marker.   
Results: 
 The three phenotypic biofilm charac- 
terization methods used yielded varying 
results. The CRA method indicated that 39 
(78%) of the isolates were biofilm producers 
while 11 (22%) of the isolates were non-biofilm 
producers as shown in Fig 1. However, the tube 
method indicated that 12 (24%) were strong 
biofilm producers, 26 (52%) were moderate 
biofilm producers and 12 (24%) were non-bio- 
film producers. The standard TCP assay 
showed that strong biofilm producers (OD > 
0.240) were 13 (26%), moderate biofilm pro- 
ducers were 22 (44%) and weak or non-biofilm 
producers (OD < 0.120) were 15 (30%). The 
tube method showed a good correlation with 
the TCP for strong biofilm producers as shown 
in Fig 2.      
 Despite the phenotypic display of bio- 
film formation by the S. aureus isolates, only 
10 (20%) harboured clumping factor encoding 
gene (clfA) while the intracellular adhesion 
encoding gene (icaA) was detected in 31 (62%) 
isolates as shown in Fig 3. 
 
Statistical analysis 
 Microsoft Excel (Microsoft Cooperation, 
2013 USA) was used to generate graphics and 
determine percentages  
 




Fig 2: Frequency (%) of strong, moderate and weak biofilm formation among Staphylococcus aureus isolates by the 
tube (A) and TCP (B) methods 





Lane M: 100bp molecular marker, Lane PC: Positive control, Lane 1-16 with the exception of Lane 5 are positive for icaA gene 
Fig 3: Agarose gel image showing the 151 bp icaA gene detected in Staphylococcus aureus isolates 
Discussion:     method. In a similar study by Sharvari and 
Chitra (15), a higher percentage (25.3%) was 
reported. The higher percentage reported in 
our study using the CRA method could be 
attributed to a modification in the preparation 
of the CRA in our laboratory by filter sterili- 
zation of the Congo red before addition to the 
molten autoclaved brain heart infusion agar.   
 Clumping factor A (clfA) has been 
reported to mediate adhesion to fibrinogen 
thereby enhancing the formation of biofilm in 
S. aureus. In the report of Wolz et al., (16), 
staphylococcal clfA cloned into Streptococcus 
gordonii and Lactococcus lactis which lack 
surface adhesion potentially gained the ability 
and were able to cause endocarditis in an 
animal model. PCR assay of clfA in this study 
revealed that 24% of the S. aureus isolates 
possessed the gene. In a similar study, 
Nourbakhsh and Namvar (17) reported a 
slightly higher carriage rate (41.4%) of clfA 
gene in S. aureus isolated from nosocomial 
infection in Isfahan Iran. As opposed to the low 
occurrence of clfA genes in our isolates, 
majority (62%, n=31) of them carried icaA 
gene. Kifaya et al., (18) reported that all S. 
aureus isolates assayed for icaA gene were 
positive for the gene and they all pheno- 
typically formed biofilm, which agrees with our 
study where all 31 isolates carrying icaA gene 
phenotypically formed biofilm. The correlation 
of biofilm formation and the possession of icaA 
gene was also reported by Namvar et al., (12). 
 Biofilm forming S. aureus has been 
linked to life threatening infections that defies 
antimicrobial therapy due to resistance, which 
encourage persistence and easy dissemination 
(12). In this study, the TCP assay method 
revealed that 13 (26%) of the S. aureus 
isolates screened were strong biofilm formers, 
44% were moderate biofilm formers, and 30% 
were weak or non-biofilm formers. This is 
similar to the findings of Mathur et al. (9) who 
reported 14.47%, 39.4%, and 46.0% as 
strong, moderate and weak S. aureus biofilm 
formers respectively. This method gives the 
best discrimination between strong, moderate 
and non-biofilm formers as it used cut-off 
values.     
 Although the tube method correlated 
well with the TCP strong biofilm formers in this 
study, weak formers were difficult to discri- 
minate from non-biofilm formers. The tube 
method detected slightly lower number of 
strong biofilm formers with 24%, which was 
lower in comparison to the TCP method with 
26%. However, the observation of Flemming et 
al., (13) showed that TCP method detected 
69% of biofilm formers, whereas, TM detected 
only 36%. The authors further opined that this 
method could discriminate between strong and 
moderate biofilm formers since it is a quanti- 
tative method.     
 In this study, CRA detected 78% S. 
aureus isolates that were biofilm formers and 
22% non-biofilm formers. However, this is at 
variance with previous observations made by 
Mathur et al., (9) and Taj et al., (14) who 
reported very low percentage 5.3%, and 3.4% 
of biofilm formers respectively by the CRA 
Conclusion: 
 Biofilm formation by microbial patho- 
gens remains a great threat in the healthcare 
sector because infections caused by them are 




associated with increased morbidity and 
mortality, as well as contributing to significant 
financial burden on the economy. Hence, the 
use of nanoparticles that have been shown to 
compromise integrity or destroy biofilms, may 
be explored in tackling the challenges of biofilm 
forming pathogens.   
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